GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shangya Technology Co Ltd (ROCO:6130) » Definitions » Valuation Rank

Shangya Technology Co (ROCO:6130) Valuation Rank


View and export this data going back to 2002. Start your Free Trial

What is Shangya Technology Co Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.


Shangya Technology Co Valuation Rank Related Terms

Thank you for viewing the detailed overview of Shangya Technology Co's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Shangya Technology Co (ROCO:6130) Business Description

Traded in Other Exchanges
N/A
Address
Nanjing East Road, 9th Floor - 12, No. 188, Section 5, Songshan District, Taipei, TWN, 10571
Shangya Technology Co Ltd Formerly Singbao International Co Ltd is a Taiwan-based company involved in various activities of research and development. The Company's main business activities include research, development, production, and sales of wireless communication integrated circuits, satellite positioning system integrated circuits, and portable product ICs. The company segments are divided into the pharmaceutical business department, the product department, and others. The company derives the majority of its revenue from the pharmaceutical business department. which is responsible for the sales of Western medicines.